Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Eye Drops for Dry Eye Disease
NCT05784519Phase 1Active, not recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2023
- Primary completion
- Jul 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in dry eye disease (DED), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Ocular Surface Disease Index at 1 week and Schirmer test at 1 week. Started Sep 2023; status: active, not recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05784519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05784519.